18F AlF-NOTA-FAPI-04 PET/CT scans can predict pathologic complete response in patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer | Synapse
March 3, 2026
18F AlF-NOTA-FAPI-04 PET/CT scans can predict pathologic complete response in patients receiving neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Puntos clave
Pathologic complete response was significantly predicted by PET/CT scans, enhancing treatment decisions.
The study involved patients undergoing neoadjuvant chemoradiotherapy for locally advanced rectal cancer over a specific timeframe.
These scans measure biomarkers indicative of treatment effectiveness, allowing for earlier intervention when needed.
The findings highlight the potential of imaging techniques in personalizing cancer treatment strategies.